Hi William:
Is this an animal derived or human derived collagen product?
For animal derived, as long as you stay within the indications of a KGN wound management device the device will be reviewed by CDRH. However, if your company wants to make claims that have a biological mode of action, then the device may be reviewed by CBER. It should be noted that the KGN product code has a narrow definition and should not be sold or marketed as a skin substitute. You can see at the below link that these products are currently reviewed by the surgical and infection control devices group.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=KGNThe topic of human collagen products for wound management has had some press lately about how they are regulated. If this is the case- I can send you to some resources that may be of assistance.
Hope this is helpful!
------------------------------
Andrea Pilon Artman, MS, CQE
President & Principal Consultant
SpectRA Compliance, LLC
Frederick, MD
USA
andrea.artman@spectracompliancellc.com------------------------------
Original Message:
Sent: 16-May-2019 17:46
From: William Coulston
Subject: Collagen as a Biologic
Colleagues,
I am trying to put a rumor to bed within my company concerning collagen products in the KGN product code being regulated by CBER versus CDRH. I don't believe this to be true but am reaching out as part of my due diligence. Has anyone heard anything long these lines?
Thanks,
------------------------------
William Coulston PMP, MS, RAC
Quality & Regulatory Manager
San Antonio TX
United States
------------------------------